Defense Research and Development Organization (DRDO) has recently developed a Covid 19 antibody detection kit.
The antibody detection kit – DIPCOVAN can detect both spike as well as nucleocapsid proteins of Coronavirus with a high sensitivity of 97 percent.
The kit DIPCOVAN has been approved by the Indian Council of Medical Research (ICMR).
It has been developed by the Defence Institute of Physiology and Allied Sciences lab of DRDO in association with Delhi’s Vanguard Diagnostics Private Limited.
“DIPCOVAN is intended for the qualitative detection of IgG antibodies in human serum or plasma, targeting SARS-CoV-2 related antigens. It offers a significantly faster turnaround time of just 75 minutes to conduct the test without any cross-reactivity with other diseases. The kit has a shelf life of 18 months,” a statement released by DRDO stated on Friday.
DRDO develops COVID-19 antibody detection kit DIPCOVAN. The kit can detect spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus.#AtmanirbharBharat https://t.co/ubsrYIxGyo pic.twitter.com/B356vaeKYG
— DRDO (@DRDO_India) May 21, 2021
It added that the indigenously developed by scientists was tested on more than 1,000 patient samples at various Covid hospitals of Delhi.
Moreover, three batches of the product had received validation last year too.
The kit will be very useful for understanding COVID‐19 epidemiology and assessing an individual’s previous SARS‐CoV‐2 exposure.
— PIB India (@PIB_India) May 21, 2021
With regard to the manufacturing and sale of the product, DRDO said that it has received regulatory approval from the Drugs Controller General of India (DCGI), the Central Drugs Standard Control Organization (CDSCO) as well as the Ministry of Health and Family Welfare.
The kit will be very useful for understanding Covid 19 epidemiology and accessing an individual’s previous SARS-CoV-2 exposure.